Smith & Nephew plc (LON:SN) insider Graham Baker acquired 1,000 shares of Smith & Nephew stock in a transaction that occurred on Tuesday, February 27th. The shares were purchased at an average cost of GBX 1,283 ($17.73) per share, with a total value of £12,830 ($17,725.89).
Smith & Nephew plc (LON:SN) traded up GBX 7.50 ($0.10) during trading on Tuesday, reaching GBX 1,284 ($17.74). The company’s stock had a trading volume of 1,781,719 shares, compared to its average volume of 2,810,000. The stock has a market capitalization of $11,160.00 and a P/E ratio of 1,975.38. Smith & Nephew plc has a one year low of GBX 1,173 ($16.21) and a one year high of GBX 1,442 ($19.92).
The business also recently declared a dividend, which will be paid on Wednesday, May 9th. Shareholders of record on Thursday, April 5th will be given a dividend of $0.23 per share. This is an increase from Smith & Nephew’s previous dividend of $0.12. The ex-dividend date is Thursday, April 5th. This represents a yield of 1.34%.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.